These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Kotecha SA; Oak JN; Jackson MF; Perez Y; Orser BA; Van Tol HH; MacDonald JF Neuron; 2002 Sep; 35(6):1111-22. PubMed ID: 12354400 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases. Wang C; Buck DC; Yang R; Macey TA; Neve KA J Neurochem; 2005 May; 93(4):899-909. PubMed ID: 15857393 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling. Glovaci I; Caruana DA; Chapman CA Neuroscience; 2014 Jan; 258():74-83. PubMed ID: 24220689 [TBL] [Abstract][Full Text] [Related]
6. Experimental systems for studying the role of G-protein-coupled receptors in receptor tyrosine kinase signal transduction. Pyne NJ; Waters C; Moughal NA; Sambi B; Connell M; Pyne S Methods Enzymol; 2004; 390():451-75. PubMed ID: 15488194 [TBL] [Abstract][Full Text] [Related]
7. D(4) dopamine receptor differentially regulates Akt/nuclear factor-kappa b and extracellular signal-regulated kinase pathways in D(4)MN9D cells. Zhen X; Zhang J; Johnson GP; Friedman E Mol Pharmacol; 2001 Oct; 60(4):857-64. PubMed ID: 11562449 [TBL] [Abstract][Full Text] [Related]
8. Aberrant CaMKII activity in the medial prefrontal cortex is associated with cognitive dysfunction in ADHD model rats. Yabuki Y; Shioda N; Maeda T; Hiraide S; Togashi H; Fukunaga K Brain Res; 2014 Apr; 1557():90-100. PubMed ID: 24561222 [TBL] [Abstract][Full Text] [Related]
9. D2-class dopamine receptor inhibition of NMDA currents in prefrontal cortical neurons is platelet-derived growth factor receptor-dependent. Beazely MA; Tong A; Wei WL; Van Tol H; Sidhu B; MacDonald JF J Neurochem; 2006 Sep; 98(5):1657-63. PubMed ID: 16879713 [TBL] [Abstract][Full Text] [Related]
10. Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization. Chi SS; Vetiska SM; Gill RS; Hsiung MS; Liu F; Van Tol HH Mol Brain; 2010 Jul; 3():22. PubMed ID: 20659339 [TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinase-G-protein-coupled receptor signalling platforms: out of the shadow? Pyne NJ; Pyne S Trends Pharmacol Sci; 2011 Aug; 32(8):443-50. PubMed ID: 21612832 [TBL] [Abstract][Full Text] [Related]
13. Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. van Biesen T; Hawes BE; Luttrell DK; Krueger KM; Touhara K; Porfiri E; Sakaue M; Luttrell LM; Lefkowitz RJ Nature; 1995 Aug; 376(6543):781-4. PubMed ID: 7651538 [TBL] [Abstract][Full Text] [Related]
14. Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. González S; Rangel-Barajas C; Peper M; Lorenzo R; Moreno E; Ciruela F; Borycz J; Ortiz J; Lluís C; Franco R; McCormick PJ; Volkow ND; Rubinstein M; Floran B; Ferré S Mol Psychiatry; 2012 Jun; 17(6):650-62. PubMed ID: 21844870 [TBL] [Abstract][Full Text] [Related]
15. The dopamine D4 receptor: biochemical and signalling properties. Rondou P; Haegeman G; Van Craenenbroeck K Cell Mol Life Sci; 2010 Jun; 67(12):1971-86. PubMed ID: 20165900 [TBL] [Abstract][Full Text] [Related]
16. The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction. Waters C; Pyne S; Pyne NJ Semin Cell Dev Biol; 2004 Jun; 15(3):309-23. PubMed ID: 15125894 [TBL] [Abstract][Full Text] [Related]
17. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884 [TBL] [Abstract][Full Text] [Related]
18. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. Barth V; Need AB; Tzavara ET; Giros B; Overshiner C; Gleason SD; Wade M; Johansson AM; Perry K; Nomikos GG; Witkin JM J Pharmacol Exp Ther; 2013 Feb; 344(2):501-10. PubMed ID: 23197772 [TBL] [Abstract][Full Text] [Related]